Persistent Fatigue in Sarcoidosis with No Other Signs of Disease Activity
Clinical Scenario
Despite adequate treatment of other disease manifestations, a substantial number of sarcoidosis patients continue to experience significant fatigue. This scenario — persistent fatigue with no other current signs of active sarcoidosis — represents a distinct clinical challenge requiring a targeted approach.
Evidence suggests that fatigue may persist even after all other manifestations of sarcoidosis have resolved, making it a recognised complication in its own right.
Treatment Approach (partial overview)
Management in this setting combines lifestyle measures and structured rehabilitation with the potential addition of pharmacological support for selected patients.
The full protocol — including specific agents, selection criteria, and the complete management algorithm — is available via the link below.
Treatment Goal
Meaningful reduction in sarcoidosis-associated fatigue and restoration of functional capacity.
References
- Despite adequate treatment for other manifestations of sarcoidosis, a substantial number of sarcoidosis patients suffer from persistent fatigue.
- Recent studies suggest that fatigue may persist after all other manifestations of sarcoidosis have resolved.
- In a recent small double-blinded, placebo-controlled crossover study, the stimulant dexmethylphenidate hydrochloride (d-MPH) was associated with a significant reduction in sarcoidosis-associated fatigue.
- Besides medication, cognitive-behavioral therapy may also be considered as treatment strategy.
View source ↗